Physician profile
Timothy Yeh
NPI 1275591463
$18,644.81
in general payments reported to CMS, 2019-2025
20 companies · $1,578 in 2025
The $1,578 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,642 · 2020: $1,322 · 2021: $2,796 · 2022: $2,204 · 2023: $3,473 · 2024: $2,629 · 2025: $1,578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,870 · Travel and Lodging: $2,810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,869.98 |
| Travel and Lodging | $2,810.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $9,214.22 | 2019-2025 | Aveir, Gallant, Thoratec Heartmate 3 Lvas Implant Kit |
| Boston Scientific Corporation | $4,650.25 | 2019-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor, Farapulse |
| Biosense Webster, INC. | $1,584.24 | 2020-2025 | Carto 3, Nuvision Ice Catheter, Octaray Mapping Catheter |
| Medical Device Business Services, INC. | $905.63 | 2023 | Carto 3 |
| Medtronic, INC. | $898.05 | 2021-2025 | Affera Mapping System, Micra |
| Medtronic Vascular, INC. | $296.43 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $282.09 | 2022-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $182.42 | 2021-2024 | Xarelto |
| Atricure, INC. | $114.10 | 2022-2023 | |
| Becton, Dickinson and Company | $90.55 | 2021-2022 | |
| Cardiva Medical, INC. | $89.23 | 2022-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Biotronik INC. | $78.56 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $49.61 | 2019-2021 | |
| Kestra Medical Technology Services, INC. | $47.35 | 2024-2025 | Assure Wcd |
| Abiomed | $32.65 | 2024 | Impella |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $29.38 | 2023 | |
| Teleflex LLC | $29.15 | 2019 | |
| Cardiovascular Systems INC. | $26.46 | 2019 | |
| Cordis US Corp. | $23.03 | 2025 | Mynx Control |
| Pfizer INC. | $21.41 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Yeh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.